Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 163
Selected: 0
NCT IDTitle
NCT01007890Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
NCT04084678A Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH
NCT00325403FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
NCT01560637An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension
NCT04707664Sargramostim Use in COVID-19 to Recover Patient Health
NCT00911248PTC299 for Treatment of Neurofibromatosis Type 2
NCT01165476Comparative Bioavailability of Treprostinil Diethanolamine Manufactured by Two Independent Facilities
NCT02276872Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years
NCT04090866Cardiac Metabolic Remodeling After Pulmonary Vasodilator Therapy in Pulmonary Arterial Hypertension: A Pilot Study
NCT03794583Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
NCT04850105A Non-interventional Cohort Safety Study of Patients With hATTR-PN
NCT00848939Pharmacokinetics of Oral Treprostinil in Patients With Systemic Sclerosis
NCT03888365Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH
NCT02663895Safety and Efficacy of Oral Treprostinil in the Treatment of Calcinosis in Patients With Systemic Sclerosis
NCT01557647Safety and Efficacy of Inhaled Treprostinil in Patients With PAH
NCT01566877A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7288 in Healthy Adult Volunteers
NCT06814717A Safety, Tolerability and Pharmacokinetic Study of cP12 in Adults With Up To 5% Total Body Surface Area Burns
NCT00963001Effect of Food on the Pharmacokinetics of Oral Treprostinil
NCT03055234Study to Evaluate Efficacy and Safety of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Sickle Cell Disease (SCD)
NCT01043627Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR)
NCT05060315Evaluate Real-World Use of Next Generation Infusion Pumps to Administer Remodulin
NCT04865393Phase 1 Study of PK and Safety of SPR206 in Subjects With Various Degrees Of Renal Function
NCT04341948Treatment of Post-Operative Pain Following Orthopedic Surgery With SPRINT® Peripheral Nerve Stimulation (PNS) System
NCT01321073DelIVery for Pulmonary Arterial Hypertension (PAH) & Continued Support Study
NCT02573896Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells
NCT06911632Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
NCT00067041Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass Graft
NCT00060996Study of Remodulin in Patients With Critical Limb Ischemia With No Planned Revascularization Procedures
NCT00439946Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH
NCT01592045ch14.18 Pharmacokinetic Study in High-risk Neuroblastoma
NCT00159250Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy
NCT03047369The Myelin Disorders Biorepository Project
NCT03683186A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
NCT01393795Qutenza®-Remodulin® in Pulmonary Arterial Hypertension Patients
NCT01557660Inhaled Treprostinil for PAH: Open-label Extension
NCT02893995Safety, Tolerability, Pharmacokinetics and Efficacy of Two Different Rates of Subcutanous Remodulin® Dose Titration in Pulmonary Arterial Hypertension
NCT07224763Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD
NCT06878560Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD
NCT04005469Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation
NCT01795950Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH)
NCT02693171Post-Marketing Assessment of Immunogenicity and Safety of Unituxin® in High-Risk Neuroblastoma Patients
NCT05776225Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
NCT05943535Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
NCT02603068Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis
NCT03098030Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer
NCT01302444Treprostinil Combined With Tadalafil for Pulmonary Hypertension
NCT05101564Umbrella Trial of Subtype-Targeted Therapies in ER+/HER2- Breast Cancer
NCT05255991Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
NCT03497689EXPEDITE: A Study of Remodulin Induction Followed by Orenitram Optimization to Treat Pulmonary Arterial Hypertension
NCT05421897Rapid Administration Pilot for Infusing Dinutuximab